Targeting IL-11R/EZH2 signaling axis as a therapeutic strategy for osteosarcoma lung metastases

MLA

Eswaran Devarajan, et al. “Targeting IL-11R/EZH2 Signaling Axis as a Therapeutic Strategy for Osteosarcoma Lung Metastases.” Discover Oncology, vol. 15, no. 1, June 2024, pp. 1–14. EBSCOhost, https://doi.org/10.1007/s12672-024-01056-3.

APA

Eswaran Devarajan, R. Eric Davis, Hannah C. Beird, Wei-Lien Wang, V. Behrana Jensen, Arumugam Jayakumar, Cheuk Hong Leung, Heather Y. Lin, Chia-Chin Wu, Stephanie A. Ihezie, Jen-Wei Tsai, P. Andrew Futreal, & Valerae O. Lewis. (2024). Targeting IL-11R/EZH2 signaling axis as a therapeutic strategy for osteosarcoma lung metastases. Discover Oncology, 15(1), 1–14. https://doi.org/10.1007/s12672-024-01056-3

Chicago

Eswaran Devarajan, R. Eric Davis, Hannah C. Beird, Wei-Lien Wang, V. Behrana Jensen, Arumugam Jayakumar, Cheuk Hong Leung, et al. 2024. “Targeting IL-11R/EZH2 Signaling Axis as a Therapeutic Strategy for Osteosarcoma Lung Metastases.” Discover Oncology 15 (1): 1–14. doi:10.1007/s12672-024-01056-3.